Quetiapine Fumarate Tablet, Film Coated
Product Images NDC 16571-718

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 16571-718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Quetiapine Fig1)

The text describes a figure showing the Kaplan-Meler Curves of Time to Recurrence of A Mood Event in Study 7, along with the proportion of patients who experienced relapse as a percentage. No further information is available.*

FDA Label Image

Figure2 (Quetiapine Fig2)

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablets Bottle))

Each coated tablet of Rising M contains 25 mg of quetiapine, which is equivalent to the US Pharmacopeia standards. The tablets are manufactured in India and distributed by Bing Pharma Holdings. The prescription information recommends storing the tablets at room temperature, and excursions permitted to 15-30°C. A medication guide is provided separately. The warning instructs to keep medication out of children's reach. The rest of the text is not readable.*

FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablets Bottle))

This is a product description of Quetiapine tablets, USP manufactured by Rising Pharma Holdings, Inc. The usual dosage is mentioned on the accompanying prescribing information. Each film-coated tablet contains 57561 mg of quetiapine fumarate USP equivalent to 50 mg quetiapine. It is advised to store the medicine at 20° to 25°C (68° to 77°F) with excursions permitted up to 15° to 30°C (59° to 86°F) as per USP Controlled Room Temperature. The pack contains 100 tablets. However, the text also includes some unclear characters, numbers, and special characters that do not contribute to the description.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablets Bottle))

This is a description of a medication. The medication is Quetiapine, which is in the form of Tablets, USP. The tablets contain 115.122 mg of Quetiapine fumarate, which is equivalent to 100 mg of Quetiapine. The medicine is manufactured by Rising Pharma Holdings, Inc. and distributed by Eochfimcoated abetcontans. The prescription information warns that the medication must be stored at 20°C to 25°C and that excursions pemitted 0 15° 030°C. Pharmacies should dispense the medication with a separate medication guide. The rest of the text appears to be printing instructions and non-relevant information.*

FDA Label Image

Package Label-principal Display Panel (150 mg (100 Tablets Bottle))

PERiSInG NDC 16571-800-01 is a medication containing quetiapine fumarate used for treating certain mental/mood conditions. Each film-coated tablet contains 172.683 mg of quetiapine fumarate (USP equivalent to 150mg quetiapine). It should be stored in an area with temperature ranging from 15° to 30°C. The usual dosage is mentioned in the accompanying Tablets’ USP Prescribing Information. The medication should be kept out of reach of children.*

FDA Label Image

Package Label-principal Display Panel (200 mg (100 Tablets Bottle))

This is a description of a medication called "Rising NDC 16571-720-01" which contains 230.244mg of Quetiapine fumarate, equivalent to 200mg of Quetiapine Sestepine. The usual dosage can be found in the accompanying tablets USP prescribing information. It is distributed by Rising Pharma Holdings, Inc. and should be stored at 20° to 25°C (68° to 77°F). The warning indicates that it is important to keep the medication out of reach of children. There is also some information related to printing guidelines in the over printing zone coding area.*

FDA Label Image

Package Label-principal Display Panel (300 mg (100 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (400 mg (100 Tablets Bottle))

This is a medication called Quetiapine in the form of tablets. Each tablet contains 460.488 mg of Quetiapine fumarate USP equivalent to 400 mg Quetiapine. It is to be dispensed with the medication guide provided separately. The usual dosage can be found in the accompanying prescribing information. It should be stored at a temperature range of 20° to 25°C (68° to 77°F) with excursions permitted from 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. This medication should be kept out of the reach of children. It is distributed by Rising Pharma Holdings, Inc., East Brunswick, NJ 08816 and made in India with a code: TS/DRUGS/19/1993, issued on 06/2021. The text in the overprinting zone coding area cannot be printed.*

FDA Label Image

Chemical Structure (Quetiapine Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.